Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stijn L W Koolen

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Clinical Pharmacokinetics|February 5, 2025
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug OlaparibJoanneke K Overbeek, Nielka P van Erp, David M Burger, et al.
Clinical Pharmacokinetics|August 16, 2023
Therapeutic Drug Monitoring of Kinase Inhibitors in OncologyMaud B A van der Kleij, Niels A D Guchelaar, Ron H J Mathijssen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 3, 2023
Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasmaStefan A J Buck, Peter de Bruijn, Inge M Ghobadi-Moghaddam-Helmantel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 30, 2022
Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the NetherlandsAnne Kleijburg, C Louwrens Braal, Justin D Westenberg, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2019
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functionsNikki de Rouw, Sabine Visser, Stijn L W Koolen, et al.
Pharmaceutics|June 2, 2021
Development of [<sup>225</sup>Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPCEline L Hooijman, Yozlem Chalashkan, Sui Wai Ling, et al.
British Journal of Cancer|February 10, 2025
Pseudo acute kidney injury in patients receiving CDK4/6 inhibitorsSanne M Buijs, Elisabeth M Jongbloed, Lotte E M van Bergen, et al.
Breast Cancer Research and Treatment|July 16, 2022
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trialC Louwrens Braal, Justin D Westenberg, Sanne M Buijs, et al.
Pharmaceuticals (Basel, Switzerland)|January 13, 2021
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular CarcinomaKoen G A M Hussaarts, Leni van Doorn, Sander Bins, et al.
The British Journal of Surgery|May 9, 2024
Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysisNiels A D Guchelaar, Kazem Nasserinejad, Bianca Mostert, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Clinical Pharmacokinetics|February 5, 2025
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug OlaparibJoanneke K Overbeek, Nielka P van Erp, David M Burger, et al.
Clinical Pharmacokinetics|August 16, 2023
Therapeutic Drug Monitoring of Kinase Inhibitors in OncologyMaud B A van der Kleij, Niels A D Guchelaar, Ron H J Mathijssen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 3, 2023
Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasmaStefan A J Buck, Peter de Bruijn, Inge M Ghobadi-Moghaddam-Helmantel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 30, 2022
Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the NetherlandsAnne Kleijburg, C Louwrens Braal, Justin D Westenberg, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2019
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functionsNikki de Rouw, Sabine Visser, Stijn L W Koolen, et al.
Pharmaceutics|June 2, 2021
Development of [<sup>225</sup>Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPCEline L Hooijman, Yozlem Chalashkan, Sui Wai Ling, et al.
British Journal of Cancer|February 10, 2025
Pseudo acute kidney injury in patients receiving CDK4/6 inhibitorsSanne M Buijs, Elisabeth M Jongbloed, Lotte E M van Bergen, et al.
Breast Cancer Research and Treatment|July 16, 2022
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trialC Louwrens Braal, Justin D Westenberg, Sanne M Buijs, et al.
Pharmaceuticals (Basel, Switzerland)|January 13, 2021
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular CarcinomaKoen G A M Hussaarts, Leni van Doorn, Sander Bins, et al.
The British Journal of Surgery|May 9, 2024
Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysisNiels A D Guchelaar, Kazem Nasserinejad, Bianca Mostert, et al.
Pageof 13